BIOLIGANDS ApS: Financial statements 2018
CVR: 26603110
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
BIOLIGANDS ApS (CVR 26603110) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -7,229 and a net result of DKK -7,229 compared with DKK -5,158 the year before. Equity in the 2018 report amounted to DKK 96,244. The solvency ratio was 93.5%.
- Gross Profit
- DKK -7,229
- Profit/Loss
- DKK -7,229
- Equity
- DKK 96,244
- Total Assets
- DKK 102,910
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -7 t. | -7 t. | 96 t. | - |
| 2017 | - | -5 t. | -5 t. | 103 t. | - |
| 2016 | - | -4 t. | -4 t. | 109 t. | - |
| 2015 | - | -11 t. | 27 t. | 113 t. | - |
| 2014 | - | -60 t. | -161 t. | 86 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BIOLIGANDS ApS
BIOLIGANDS ApS is a Danish company of the type Anpartsselskab based in Odense SV, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Esben Nørgaard Flindt. The board consists of Rasmus Koefoed Petersen. The company's owners include Esben Nørgaard Flindt, Karsten Kristiansen and Hongbin Zhang. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700.